Skip to product information
1 of 1

Chateau Canon 2005

Chateau Canon 2005

RP95 WS93 VN95 CT92

Regular price HK$1,491.00
Regular price Sale price HK$1,491.00
Sale Sold out
Tax included.

*Note: Ratings may not be the most up-to-date

*Note: image is for reference only and may not be identical to the actual product

Type: Red

Country: France

Region: Bordeaux

Grape Variety: Blend

Vintage: 2005

Size: 750mL

RP95 - Neal Martin - Wine Advocate

"Tasted at the Château Canon vertical, the 2005 Canon is evolving into a quite gorgeous Saint Emilion. One can still discern those brown spices infiltrating the ripe red and black fruit. There is fine mineralité here, great focus, perhaps just a hint of dried blood that develops with time. The palate is medium-bodied with supple, ripe tannin. It is a very complex Saint Emilion with immense purity and style, a wine that you have to keep coming back to in order to understand. It's at that pivotal stage between primary and secondary notes, the red and black fruit being overtaken by cedar, morels and a touch of game. It gently lifts and fans out to a quite captivating finish. Dare I say that the 2005 Canon is the pick of the three over 2009 and 2010? There...I've said it...it is a quite brilliant wine."

RP95 - Antonio Galloni - Vinous

"The 2005 Canon is all brawn and muscle. Chunky tannins give the 2005 a decidedly virile feel. There is plenty of depth and freshness - this is after all one of the very best sites in all of Bordeaux - so the 2005 will hold for many years to come. Dark fruit, leather, smoke, gravel, crushed rocks and spice linger on the potent finish. Tasting the 2005 today really highlights how far Canon has come in recent years"

RP93 - Wine Spectator - Wine Spectator

"Shows a lightly roasted edge at first, with raspberry and boysenberry confiture notes laced with melted licorice, singed alder and firm graphite details. Reveals a fine chalky hint, but this has more bass than treble overall. Still rather tight.—Non-blind Canon vertical (December 2016). Best from 2020 through 2030. 4,200 cases made."

View full details